Results 191 to 200 of about 393,252 (329)

Biological Treatment of Chronic Rhinosinusitis With Polyps Increases Number of Nasal Ciliated Cells—Real‐Life Experience

open access: yes
Allergy, EarlyView.
Grażyna Stryjewska‐Makuch   +8 more
wiley   +1 more source

5‐HT7 antagonists confer analgesia via suppression of neurotrophin overproduction in submucosal nerves of mouse models with visceral hypersensitivity

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Schematic diagram of intestinal nerve abnormality underlying the mechanisms of visceral hypersensitivity. In physiological conditions with normal sensation, enteric neurons are situated in the submucosal and myenteric plexuses, and the spinal afferent fibres ramify within the enteric plexus. However, serotonin/5‐hydroxytryptamine
Tzu‐Yi Lee   +9 more
wiley   +1 more source

Role and Mechanism of Olfactory Stem Cells in the Treatment of Olfactory Disorders

open access: yesStem Cells International
Olfactory dysfunction is one of the most prevalent diseases in otorhinolaryngology, particularly since the coronavirus 2019 (COVID-19) pandemic, with a potential impact on daily life.
Shengqi Gan   +5 more
doaj   +1 more source

Intranasally applied human olfactory mucosa neural progenitor cells migrate to damaged brain regions. [PDF]

open access: yesFuture Sci OA, 2022
Kronner JM   +5 more
europepmc   +1 more source

Expression of IL‐4 Receptor Alpha in Ectopic Lymphoid Tissue in Chronic Rhinosinusitis

open access: yes
Allergy, EarlyView.
Kengo Kanai   +9 more
wiley   +1 more source

Single‐cell transcriptomics of human organoid‐derived enteroendocrine cell populations from the small intestine

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Human intestinal organoids were genetically modified to express a fluorescent protein in enteroendocrine cells (EECs), which were then separated by flow cytometry and analysed by single‐cell RNA sequencing. High numbers of human EECs were thereby available for cluster analysis and differential gene expression, revealing ...
Christopher A. Smith   +7 more
wiley   +1 more source

Transforming Growth Factor‐Beta Signaling in Cancer: Therapeutic Implications, Challenges, and Pathways to Progress

open access: yesMedComm – Oncology, Volume 4, Issue 3, September 2025.
TGF‐β inhibition is emerging as a promising cancer therapy, yet translating laboratory success to bedside implementation has suffered significant setbacks. The associated challenges include adverse drug reactions, inadequate predictive models, and activation of alternative signaling pathways.
Faizah A. Alabi   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy